Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.
7 reports, 3 independent
Updated Sep 21
Gone quiet
- Reports
- 7
- Developments
- 2
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley raised Moderna price target as President Hoge sold shares.1 source
President of Moderna sold company stock under a trading plan, leading to SEC filings.1 source
Keep exploring
The entities involved
-
Moderna
American biotechnology company
-
Securities and Exchange Commission
government agency of the Philippines
-
Stephen Hoge
researcher
Nothing else this week.
Related events
- Filings regarding stock trading activity were made involving the SEC and Nasdaq on July 25, 2026.
- Woodward filed reports with the Securities and Exchange Commission regarding its stock activity on August 19, 2026.
- F5, Inc. filed disclosures regarding share purchases with the Securities and Exchange Commission.
- SEC received filings regarding stock holdings from Williams Companies on September 22, 2026.
- Hewlett Packard Enterprise filed a disclosure with the Securities and Exchange Commission regarding share purchases on August 31, 2026.